Clinical Trials Logo
  1. Home
  2. Androgenic Alopecia
  3. NCT03506503
  4. Details
NCT03506503 Clinical Trial

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Androgenic Alopecia Clinical Trial

Official title:
Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03506503
Other study ID # 2019004
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 27, 2019
Est. completion date May 1, 2020

Study information
Verified date February 2021
Source Jinan University Guangzhou
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc. In this clinical trial, the investigators aim to analyze the effect of nanofat grafting on treating androgenic alopecia in male.

Description:

The investigators will treat the hair loss area of a patient by processed nanofat grafting. The participants were asked to come back 1、3、6、9、12 months after treatment for further follow-up. Before and after the treatment, the hair and follicular will be assessed subjectively by satisfaction assessment, dermatoscope.

Recruitment information / eligibility
Status Completed
Enrollment 10
Est. completion date May 1, 2020
Est. primary completion date February 27, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Male patients with androgenic alopecia aging from 18 to 50. - No scars and wounds on the alopecia area. - No skin disease or serious cardiovascular disease. - Preoperative examinations remain healthy. Exclusion Criteria: - Serious chronic heart, liver, kidney, blood system disease - Allergic diseases, skin inflammation or wounds - Alopecia but not androgenic alopecia - Acute or chronic infection - Take anticoagulant drugs - Active vitiligo, psoriasis, systemic lupus erythematosus

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Nanofat grafting
hair loss area will be treated by processed autologous Nanofat grafting

Locations
Country Name City State
China the first affiliated hospital of Jinan University Guangzhou Guangdong

Sponsors (1)
Lead Sponsor Collaborator
Jinan University Guangzhou

Country where clinical trial is conducted

China, 

References & Publications (3)

Gu Z, Li Y, Li H. Use of Condensed Nanofat Combined With Fat Grafts to Treat Atrophic Scars. JAMA Facial Plast Surg. 2018 Mar 1;20(2):128-135. doi: 10.1001/jamafacial.2017.1329. — View Citation

Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013 Oct;132(4):1017-1026. doi: 10.1097/PRS.0b013e31829fe1b0. — View Citation

Won CH, Park GH, Wu X, Tran TN, Park KY, Park BS, Kim DY, Kwon O, Kim KH. The Basic Mechanism of Hair Growth Stimulation by Adipose-derived Stem Cells and Their Secretory Factors. Curr Stem Cell Res Ther. 2017;12(7):535-543. doi: 10.2174/1574888X12666170829161058. Review. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Other Satisfaction assessments the satisfaction will be assessed after the treatment 1,3,6,12 months after treatment
Primary Dermatoscope the density of hair follicle and diameter of hair will be analized by dermatoscope before and after the treatment of Nanofat grafting. Baseline and at1,3,6,9,12 months after the treatment
See also
  Status Clinical Trial Phase
Recruiting NCT06110377 - MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) Phase 4
Recruiting NCT05611593 - Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia Phase 1
Completed NCT03676400 - Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia N/A
Recruiting NCT05938569 - Computer-Assisted Hair Restoration Study Using ARTAS System N/A
Not yet recruiting NCT03474718 - Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia Early Phase 1
Not yet recruiting NCT06292533 - Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study N/A
Not yet recruiting NCT06326359 - Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia N/A
Recruiting NCT05426629 - Hydraderm for Androgenic Alopecia Phase 4
Recruiting NCT05369481 - Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia N/A
Recruiting NCT05827991 - A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia N/A
Completed NCT02824380 - Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia Phase 1
Completed NCT06112782 - Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality N/A
Completed NCT02594046 - The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia N/A
Recruiting NCT05435625 - Fractional Laser Versus Radiofrequency in Androgenetic Alopecia N/A
Completed NCT05450861 - Effect of the Composition From Fish on Promoting Hair Growth N/A
Completed NCT03467412 - To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin Phase 2
Completed NCT01852487 - Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia N/A
Active, not recruiting NCT02914587 - Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study N/A
Completed NCT04341363 - Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling N/A
Completed NCT04450602 - A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss N/A